Across all GLP-1 medications, 12-month persistence (still taking the medication at one year) ranges from 38% to 56% depending on the study and population (Wilding et al., Diabetes Obes Metab 2023)
Furthermore, although it is classified as a functional food, research on its incorporation into dietary therapies for kidney health remains limited
Extended Data Figure 4 Pharmacology of transcranial fluorescent compound administration
Analysis of immune and inflammation characteristics of atherosclerosis from different sample sources
Biochemical analyses were performed on brain tissue homogenates, quantifying GSH, GPX1, GABA, IL-6, IL-10 and TNF using ELISA-based assays
There is a growing consensus on improving compliance with T2DM treatment and increasing medication adherence with timely/early initiation of treatment to minimize risks associated with T2DM